Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization

Yasuaki Takeji1, Hiroki Shiomi1, Takeshi Morimoto2

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University.

Insights

Diabetes mellitus (DM) significantly increases heart failure (HF) risk after coronary revascularization. Insulin treatment in DM patients did not further elevate this risk compared to non-insulin-treated DM patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Research

Background:

  • The long-term impact of diabetes mellitus (DM) on heart failure (HF) risk post-coronary revascularization requires further investigation.
  • Understanding this relationship is crucial for managing cardiovascular outcomes in diabetic patients.

Purpose of the Study:

  • To evaluate the effect of diabetes mellitus (DM) status on the long-term risk of heart failure (HF) hospitalization in patients undergoing coronary revascularization.
  • To compare the risk between insulin-treated DM (ITDM) and non-insulin-treated DM (NITDM) patients.

Main Methods:

  • A cohort of 15,231 patients from the CREDO-Kyoto Registry Cohort-2 who underwent coronary revascularization were analyzed.
  • Patients were categorized into DM (n=5,999) and Non-DM (n=9,232) groups. DM patients were further divided into ITDM (n=1,353) and NITDM (n=4,646) groups.
  • The primary outcome was HF hospitalization, assessed over a 5-year period using survival analysis and adjusted for confounders.

Main Results:

  • The 5-year cumulative incidence of HF hospitalization was significantly higher in DM patients (11.0%) compared to Non-DM patients (6.6%) (P<0.0001).
  • HF hospitalization rates were also higher in ITDM patients (14.6%) versus NITDM patients (10.0%) (P<0.0001).
  • After adjustment, DM remained a significant risk factor for HF hospitalization (HR 1.47, P<0.0001), but the difference between ITDM and NITDM was not significant (HR 1.17, P=0.12).

Conclusions:

  • Diabetes mellitus significantly increases the long-term risk of heart failure hospitalization following coronary revascularization.
  • The increased risk associated with DM persists regardless of the revascularization strategy used.
  • No significant difference in HF hospitalization risk was observed between insulin-treated and non-insulin-treated DM patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
615
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603